Payments by drug and medical device manufacturers to us peer reviewers of major medical journals

JAMA

2024-10-10

(Press-News.org) About The Study: More than half of the 1,962 U.S. physicians included in this study who peer reviewed for the most influential medical journals received industry payments in 2020-2022, with most payments for research. Research payments, especially those provided to an institution, may have different implications than general payments for conflicts of interest.

Corresponding Author: To contact the corresponding author, Christopher J. D. Wallis, MD, PhD, email wallis.cjd@gmail.com.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jama.2024.17681)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.17681?guestAccessKey=4bbabdcb-70df-4352-883e-026fc020919b&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=101024

END

ELSE PRESS RELEASES FROM THIS DATE:

One-third of cancer-related crowdfunding campaigns share medical financial hardship and health-related social needs, new research shows

2024-10-10

In a new, large comprehensive analysis led by the American Cancer Society (ACS), researchers, using a form of Artificial Intelligence (AI), found that more than one-third of fundraising stories on the GoFundMe crowdfunding platform in the United States explicitly shared experiences of medical financial hardships and health-related social needs (HRSNs). The fundraising stories included hardships such as housing and food insecurities, transportation barriers, income loss, lack of sick leave, and disruptions to both work and school. The findings are published today ...

Faulty 'fight or flight' response drives deadly C. difficile infections, research reveals

2024-10-10

The portion of our nervous systems responsible for the “fight or flight” response can shape the severity of potentially deadly C. difficile infections, new research from the University of Virginia School of Medicine reveals. The findings suggest that doctors may be able to save patients from the infections – a plague for hospitals and nursing homes – by using drugs to quiet the hyperactive nervous system response, the researchers say. “Compared to how much we know about immune system influences in C. difficile infections, the field is just scratching ...

Checking out the boundaries: Milestone in lipidomics achieved

2024-10-10

Results of the first phase of a Ceramide Ring Trial have just been published in the renowned journal Nature Communications, representing a significant landmark in the field of lipidomics. This achievement, involving researchers at the University of Vienna and scientific teams in Singapore, Julich and Espoo, represents a groundbreaking advance in the establishment of ceramide reference values, plasma lipids involved in such as cardiovascular diseases. The ring trial was performed under the umbrella of the International Lipidomics Society ...

SNU-KAIST researchers jointly develop a new visible light communication encryption technology using chiral nanoparticles

2024-10-10

Seoul National University(SNU) College of Engineering announced that a joint research team led by Professor Ki Tae Nam from the Department of Materials Science and Engineering at SNU and Professor Junil Choi from the Korea Advanced Institute of Science and Technology (KAIST) has developed a novel visible light communication encryption technology with high security using chiral nanoparticles. Just as a lighthouse provides a guiding beam in the vast darkness of the sea, light-based information transmission has been a crucial means of communication throughout human history. ...

HPTN 091 study shows encouraging uptake and adherence to oral PrEP among transgender women

2024-10-10

DURHAM, N.C. – Researchers from the HIV Prevention Trials Network (HPTN) presented results from HPTN 091 (“I Am Study”) at the HIVR4P 2024 conference in Lima, Peru. The study examined the acceptability and feasibility of an integrated multicomponent strategy to enhance daily oral HIV pre-exposure prophylaxis (PrEP) uptake and adherence among transgender women in a randomized immediate versus deferred design. The integrated care strategy included the provision of gender-affirming hormone ...

Gonzalez receives award to study causes of racial disparities in amputation rates in Indiana

2024-10-10

INDIANAPOLIS --More than 8 million people, ages 40 and older, living in the U.S. are affected by peripheral arterial disease, a lifelong medical condition and the most common cause of limb amputation in the country. A data scientist, health services researcher and vascular surgeon who studies health equity, Andrew A. Gonzalez, M.D., J.D., MPH, of the Regenstrief Institute and the Indiana University School of Medicine, has received a 2024 Ralph W. and Grace M. Showalter Research Trust award to conduct a new study, Exploring Causes of Racial Disparities in Amputation Rates in Indiana. Dr. ...

Mount Sinai opens state-of-the-art center for patients with complex conditions including Lyme disease and long COVID

2024-10-10

Mount Sinai’s Department of Rehabilitation and Human Performance has announced the grand opening of the Cohen Center for Recovery From Complex Chronic Illnesses (CoRE), providing clinical care for patients with conditions such as long Lyme disease/Lyme+, long COVID, and other infection-associated complex chronic illnesses such as myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and Ehlers-Danlos syndrome (EDS). Supported by philanthropy from various donors, including an inaugural gift from Beth and ...

$14M NIH grant funds gene-editing research for rare metabolic diseases at Penn and CHOP

2024-10-10

PHILADELPHIA— A $14M grant will fund research on gene-editing therapies for rare metabolic diseases at the Perelman School of Medicine at the University of Pennsylvania (Penn) and Children’s Hospital of Philadelphia (CHOP). The research will focus specifically on developing therapies for urea cycle disorders, which impact roughly 1 in every 35,000 children. Using a form of CRISPR technology, the ultimate vision of the four-year grant is to create a platform for rapid development of personalized gene-editing therapies for ...

One experiment: The brain’s landscapers

2024-10-10

Imagine yourself sometime in the far future aboard a routine rocket to Mars. Someone just spilled their drink. Without gravity, it collects in floating blobs that ripple right before your eyes. Now freeze. What you see might look something like the above image from Cold Spring Harbor Laboratory’s (CSHL’s) Cheadle lab. But those purple and green blobs aren’t the floating remains of somebody’s drink. They’re mysterious cells in the brain’s visual cortex called OPCs. The visual cortex processes everything we see. Incoming visual information is ...

AI-supported dermatology: Now for darker skin tones too, thanks to a new data set

2024-10-10

In many countries in Africa, up to nine out of ten children suffer from a skin problem, and there are far too few local dermatologists. Artificial intelligence could help with diagnosis, but needs to be trained with the relevant images, so researchers have created a new data set for dark skin tones. Demand is high, the lack of dermatologists acute: in many countries in Africa, there is less than one dermatology specialist per one million people – compared to the World Health Organization (WHO) recommendation of ...

Research Article | Evaluation of ten satellite-based and reanalysis precipitation datasets on a daily basis for Czechia (2001–2021)

Nano-immunotherapy synergizing ferroptosis and STING activation in metastatic bladder cancer

[Press-News.org] Payments by drug and medical device manufacturers to us peer reviewers of major medical journals
JAMA

Payments by drug and medical device manufacturers to us peer reviewers of major medical journals

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: